empty
 
 
05.11.2020 11:52 AM
AstraZeneca has increased its quarterly sales, expects data from COVID-19 vaccine trials this year.

This image is no longer relevant

AstraZeneca is expected to release the highly anticipated results of the third phase of vaccine trials in the coming weeks.

At the same time, the demand for the company's drugs remained high, despite the disruptions in the work of health systems due to the pandemic.

According to the results of the financial report, the company's sales grew by 7% in the quarter ended September 30, and reached $ 6.52 billion. Revenues from co-developed drugs and currency fluctuations were not included in the calculation.

Basic earnings per share were 94 cents per share against the forecast of 98 cents.

At the end of the year, AstraZeneca expects to increase total revenue by 7-13% and increase basic earnings per share by 14-19%.

Thomas Frank,
Experto analítico de InstaForex
© 2007-2025
Summary
Urgency
Analytic
Thomas Frank
Start trade
Gana con los cambios en el valor de las criptomonedas con InstaForex.
Descarga MetaTrader 4 y abre tu primera operación.
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    UNIRSE AL CONCURSO
  • Depósito al azar
    ¡Haga un depósito en su cuenta de $3,000 y obtenga $6000 más!
    ¡En Diciembre, sorteamos $6000 dentro de la campaña Depósito afortunado!
    Obtenga la oportunidad de ganar depositando $3,000 en una cuenta de operaciones. Tras haber cumplido esta condición, se convertirá en un participante de la campaña.
    UNIRSE AL CONCURSO
  • Opere de forma inteligente, gane un dispositivo
    Recargue su cuenta con al menos $500, regístrese en el concurso y tenga la oportunidad de ganar dispositivos móviles.
    UNIRSE AL CONCURSO
  • 30% de bonificación
    Reciba un bono del 30% cada vez que recargue su cuenta
    OBTENER BONO

Recommended Stories

¿No puede hablar ahora mismo?
Ingrese su pregunta en el chat.
Widget callback